RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials.

Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials.

Add to Collection
2016 Aug RCTs Fist_Author_Year_PM

Full Author : ['Xue, X', 'Ren, Z', 'Zhang, A', 'Yang, Q', 'Zhang, W', 'Liu, F']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

BACKGROUND: Once-weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown promising results in the treatment of type 2 diabetes. Herein, we compared the efficacy and safety of once-weekly GLP-1RAs with exenatide and liraglutide separately. M.....

Keywords : ["onceweekly glucagonlike receptor agonist compare", "randomised control trial", "type diabetes", "systemic review", "safety", "liraglutide", "exenatide", "efficacy"]